Overview

Evaluation of Eflornithine on Facial and Forearm Skin

Status:
Completed
Trial end date:
2005-10-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate whether regular use of eflornithine 11.5% cream in treating women with facial hair will induce skin damage (atrophy) on the face and/or forearms
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Shire
Treatments:
Eflornithine